Our People

Having already headed up successful drug development companies, Chief Executive Officer Ian Garland and Chief Financial Officer David Mackney are the perfect team to help Vernalis realise its potential.   They form part of a talented, highly qualified and knowledgeable senior management team that lead our research programmes, supervise our clinical studies and oversee our partner collaborations.

By leveraging our skills in research, our team secured two new collaborations during 2009 and a further collaboration in 2010.  We aim to continue to build on this success in 2011. Two research programmes also entered our pipeline as pre-clinical development candidates, illustrating the productive nature of our in-house research capabilities.  

We have progressed both pre-clinical development candidates in development and hope both will enter the clinic in 2011.

Latest News